Literature DB >> 31816006

Risk of Gadolinium-Based Contrast Agents in Chronic Kidney Disease-Is Zero Good Enough?

Saugar Maripuri1,2, Kirsten L Johansen1,2.   

Abstract

Entities:  

Year:  2019        PMID： 31816006     DOI： 10.1001/jamainternmed.2019.5278

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  2 in total

1.  Use of Gadolinium in Individuals with Reduced Kidney Function.

Authors:  Kambiz Kalantari; Sundararaman Swaminathan
Journal:  Clin J Am Soc Nephrol       Date:  2021-01-11       Impact factor: 10.614

Review 2.  Use of Intravenous Gadolinium-Based Contrast Media in Patients With Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation.

Authors:  Jeffrey C Weinreb; Roger A Rodby; Jerry Yee; Carolyn L Wang; Derek Fine; Robert J McDonald; Mark A Perazella; Jonathan R Dillman; Matthew S Davenport
Journal:  Kidney Med       Date:  2020-11-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.